Clearance Summary
DUPONT ACA PLUS LUTEINIZING HORMONE (LH) METHOD received FDA 510(k) clearance under submission number K943996, sponsored by Dupont Medical Products. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1994-10-20.
- Submission: K943996
- Applicant / Sponsor: Dupont Medical Products
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class I
- Regulation citation: 21 CFR 862.1485
- Decision date: 1994-10-20
Classification & Regulation
This clearance is catalogued under FDA product code CEP and 21 CFR 862.1485, within the Clinical Chemistry review panel as a Class I device.